Terminated NA INTERVENTIONAL 2-arm NCT03420846

Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping

Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping Using Optical Coherence Tomography

Sponsor: Michelson Diagnostics Ltd.

Interventions OCT Mapped

Updated 7 times since 2018 Last updated: Jan 24, 2020 Started: Jul 1, 2018 Primary completion: Sep 1, 2019 Completion: Sep 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding exhausted. Sufficient data already collected.

This NA trial investigates Carcinoma, Basal Cell and is currently terminated or withdrawn. Michelson Diagnostics Ltd. leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Feb 2020 — Jan 2021 [monthly]

Terminated NA

Status: Recruiting → Terminated
Oct 2018 — Feb 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

May 2018 — Oct 2018 [monthly]

Not Yet Recruiting NA
Mar 2018 — May 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Michelson Diagnostics Ltd.
Skin Care Network Ltd.

Data source: Michelson Diagnostics Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom